1-4 of 4
Erick Gamelin
Close
Sort by
Journal Articles

Phase 1 Study of AMG 900, an Orally Administered Pan-Aurora Kinase Inhibitor, in Adult Patients (Pts) with Acute Myeloid Leukemia (AML)

Michael W. Schuster, MD, Mikkael A. Sekeres, MD MS, Erick Gamelin, MD PhD, Erik Rasmussen, MS, Gloria Juan, PhD, Abraham Anderson, PhD, Vincent Chow, PhD, Greg Friberg, MD, Florian D. Vogl, MD PhD, Hagop Kantarjian, MD
Journal: Blood
Blood (2015) 126 (23): 4929.
https://doi.org/10.1182/blood.V126.23.4929.4929
Published: 2015
Journal Articles

AMG 900, a Potent and Highly Selective Aurora Kinase Inhibitor Shows Promising Preclinical Activity Against Acute Myeloid Leukemia Cell Lines In Vitro and In Vivo

Kam Cheung, Gloria Juan, William Wayne, Kelly Hanestad, Kathleen Keegan, Justin Huard, Patricia McElroy, Mary K Stanton, Tammy L Bush, Richard L Kendall, Robert Radinsky, Steve Abella, Peter C Pieslor, Gregory Friberg, Angela Coxon, Erick Gamelin, Marc Payton
Journal: Blood
Blood (2013) 122 (21): 3823.
https://doi.org/10.1182/blood.V122.21.3823.3823
Published: 2013
Journal Articles

Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells

Dorothée Duluc, Yves Delneste, Fang Tan, Marie-Pierre Moles, Linda Grimaud, Julien Lenoir, Laurence Preisser, Ignacio Anegon, Laurent Catala, Norbert Ifrah, Philippe Descamps, Erick Gamelin, Hugues Gascan, Mohamed Hebbar, Pascale Jeannin
Journal: Blood
Blood (2007) 110 (13): 4319–4330.
https://doi.org/10.1182/blood-2007-02-072587
Published: 2007
Includes: Supplemental data
Journal Articles

Expression of the Multidrug Resistance-Associated Protein Gene in Refractory Lymphoma: Quantitation by a Validated Polymerase Chain Reaction Assay

Zhirong Zhan, Victor A. Sandor, Erick Gamelin, Joanna Regis, Bruce Dickstein, Wyndham Wilson, Antonio T. Fojo, Susan E. Bates
Journal: Blood
Blood (1997) 89 (10): 3795–3800.
https://doi.org/10.1182/blood.V89.10.3795
Published: 1997